Cancer and the internet: The good, the bad, and the very ugly Maurie Markman Editor’s Commentary Pages: 77 - 78
Hepatic artery infusion of chemotherapy following resection of liver metastases Richard L. Schilsky Clinical Trials Report Pages: 85 - 86
Postoperative adjuvant chemotherapy and pelvic radiotherapy for resected rectal cancer Richard L. Schilsky Clinical Trials Report Pages: 86 - 87
Virtual colonoscopy: A novel imaging modality for colorectal cancer David T. RubinAbraham H. Dachman OriginalPaper Pages: 88 - 93
Adjuvant chemotherapy for colon cancer Shaji K. KumarRichard M. Goldberg OriginalPaper Pages: 94 - 101
Determinants of prognosis and response to therapy in colorectal cancer Syma IqbalHeinz-Josef Lenz OriginalPaper Pages: 102 - 108
Therapeutic approaches to metastasis confined to the liver Alan P. VenookRobert S. Warren OriginalPaper Pages: 109 - 115
An oral fluoropyrimidine prodrug with activity in colorectal cancer Ronald M. Bukowski Clinical Trials Report Pages: 129 - 130
Biochemical modulation of fluorouracil in patients with metastatic colorectal cancer Ronald M. Bukowski Clinical Trials Report Pages: 130 - 130
Clinical studies of angiogenesis inhibitors: The university of texas md anderson center trial of human endostatin Roy S. HerbstAnh Tuyet LeeJames L. Abbruzzese OriginalPaper Pages: 131 - 140
Liposomal encapsulated anthracyclines: new therapeutic horizons Franco M. Muggia OriginalPaper Pages: 156 - 162
Recent developments in weekly paclitaxel therapy in lung cancer Wallace Akerley OriginalPaper Pages: 165 - 169
Topoisomerase i targeting agents in small-cell lung cancer Yuichiro OheNagahiro Saijo OriginalPaper Pages: 170 - 178
Multiple daily fractionation radiotherapy schedules in lung cancer Craig A. SchulzPaul M. HarariMinesh P. Mehta OriginalPaper Pages: 179 - 184